Cargando…

Changes in(18)F-FDG uptake measured by PET as a pharmacodynamic end-point in anticancer therapy. How far have we got?

Detalles Bibliográficos
Autor principal:	Price, P
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374563/ https://www.ncbi.nlm.nih.gov/pubmed/10917538 http://dx.doi.org/10.1054/bjoc.2000.1342

Ejemplares similares

Imaging of the unstable plaque: how far have we got?
por: Matter, Christian M., et al.
Publicado: (2009)

Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?
por: van Westrhenen, Roos, et al.
Publicado: (2020)

Mpox Person-to-Person Transmission—Where Have We Got So Far? A Systematic Review
por: Pinto, Pedro, et al.
Publicado: (2023)

The sex life of male patients with cirrhosis and its organic factors: What we have got so far?
por: Darmadi, Darmadi, et al.
Publicado: (2023)

Dual time point based quantification of metabolic uptake rates in (18)F-FDG PET
por: den Hoff, Jörg van, et al.
Publicado: (2013)

Modeling Water Resources: Have We Got it Right?
por: Havens, Karl E.
Publicado: (2001)

'We celebrate those who got the profession to this point'
por: Ellwood, Fiona
Publicado: (2021)

Benign Colonic (18)F-FDG Uptake on Whole-Body FDG-PET Scan
por: Jang, Byung Ik
Publicado: (2012)

Diagnosing acute compartment syndrome—where have we got to?
por: McMillan, Tristan E., et al.
Publicado: (2019)

Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?
por: Turnbull, Samantha, et al.
Publicado: (2015)

Utility of dual time point 18 FDG PET-CT
por: De Luca, SE, et al.
Publicado: (2014)

(18)F-FBPA PET in Sarcoidosis: Comparison to Inflammation-Related Uptake on FDG PET
por: Watabe, Tadashi, et al.
Publicado: (2020)

Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?
por: Ngan, Nguyen Thi Thuy, et al.
Publicado: (2022)

Emergence from anaesthesia: Have we got it all smoothened out?
por: Bhaskar, S Bala
Publicado: (2013)

Reconstructing functional brain networks: have we got the basics right?
por: Papo, David, et al.
Publicado: (2014)

Lymphoma Severity and Type Are Associated With Aortic FDG Uptake by (18)F-FDG PET/CT Imaging
por: Vlachopoulos, Charalambos V., et al.
Publicado: (2020)

(18)F-FDG-PET uptake in non-infected total hip prostheses
por: Gelderman, Stefan J, et al.
Publicado: (2018)

Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT
por: Dong, Aisheng, et al.
Publicado: (2016)

False-Positive (18)F-FDG PET/CT Uptake in Unilateral Lactation
por: Yip, Joshua Wei Liang, et al.
Publicado: (2020)

Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
por: Alkilany, Alaaldin M., et al.
Publicado: (2010)

Editorial: Have We Got Better in Making Our Schizophrenia Patients Better?
por: Jääskeläinen, Erika, et al.
Publicado: (2020)

Vitamin C for COVID-19 Treatment: Have We Got Enough Evidence?
por: Ahmad, Siti Rohaiza
Publicado: (2022)

The Skagit County choir COVID-19 outbreak – have we got it wrong?
por: Axon, C.J., et al.
Publicado: (2023)

We got rhythm a Gershwin songbook.
por: Gershwin, George, 1898-1937
Publicado: (1998)

Case report: Eosinophilic fasciitis induced by pembrolizumab with high FDG uptake on (18)F-FDG-PET/CT
por: Amrane, Karim, et al.
Publicado: (2022)

Pituitary (18)F-FDG uptake correlates with serum TSH levels in thyroid cancer patients on (18)F-FDG PET/CT
por: Ding, Yingli, et al.
Publicado: (2019)

Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
por: Gajjela, Harini, et al.
Publicado: (2021)

Factors affecting tumor (18) F-FDG uptake in longitudinal mouse PET studies
por: Sha, Wei, et al.
Publicado: (2013)

Evaluation of pituitary uptake incidentally identified on (18)F-FDG PET/CT scan
por: Ju, Huijun, et al.
Publicado: (2017)

Reflecting on the utility of standardized uptake values on (18)F-FDG PET in nasopharyngeal carcinoma
por: Qiu, Xiufang, et al.
Publicado: (2022)

The role of dual time point PET/CT for distinguishing malignant from benign focal (18)F-FDG uptake duodenal lesions
por: Sa, Ri, et al.
Publicado: (2018)

Increased (18)F-FDG Uptake in the Obturator Muscles Due to Denervation-Driven Atrophy: Teaching point: Denervated muscles can show a temporary increase in (18)F-FDG uptake on PET-CT, thus simulating malignancy
por: Panis, Thomas, et al.
Publicado: (2019)

What is the importance of solitary focal bony FDG-uptake on 18F-FDG PET-CT of known cancer patients?
por: Sonoda, LI, et al.
Publicado: (2014)

Thyroid incidentalomas with increased focal (18)F-FDG uptake in (18)F-FDG PET/CT of a patient with multiple primary cancers.
por: Mihatsch, Patrick W., et al.
Publicado: (2021)

[(18)F]FDG uptake of the normal spinal cord in PET/MR imaging: comparison with PET/CT imaging
por: Aiello, Marco, et al.
Publicado: (2020)

Diabetes: Have We Got It All Wrong?: Hyperinsulinism as the culprit: surgery provides the evidence
por: Pories, Walter J., et al.
Publicado: (2012)

Patella Resurfacing during Total Knee Arthroplasty: Have We Got the Issue Covered?
por: Sandiford, Nemandra A., et al.
Publicado: (2014)

Treating acute cough: wet versus dry – have we got the paradigm wrong?
por: Morice, Alyn H., et al.
Publicado: (2015)

Benign Intrapulmonary Schwannoma With High Uptake on Fluorodeoxyglucose-18 (FDG-18 PET) Presenting as a Pancoast Tumor
por: Chauhan, Sukhjinder, et al.
Publicado: (2023)

18-FDG PET in lung transplantation
por: Algieri, I, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pcpel94g02763dh0cal9e6qpf4